Numeric Investors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Numeric Investors’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-122,000	Closed	-$489K	–	1195
2015 Q4	$489K	Buy	122,000 +73,900	+154%	+$340K	0.01%	727
2015 Q3	$220K	Sell	48,100 -607,425	-93%	-$3.18M	﹤0.01%	912
2015 Q2	$3.4M	Buy	655,525 +100,297	+18%	+$602K	0.04%	311
2015 Q1	$3.48M	Sell	555,228 -259,205	-32%	-$1.5M	0.04%	290
2014 Q4	$5.12M	Buy	814,433 +411,083	+102%	+$2.51M	0.07%	227
2014 Q3	$2.45M	Buy	403,350 +345,438	+596%	+$2.36M	0.04%	306
2014 Q2	$382K	Buy	+57,912	New	+$652K	0.01%	619
2014 Q1	–	Sell	-266,661	Closed	-$2.85M	–	954
2013 Q4	$2.85M	Sell	266,661 -69,885	-21%	-$772K	0.05%	304
2013 Q3	$4.49M	Buy	336,546 +17,436	+5%	+$276K	0.08%	224
2013 Q2	$4.19M	Buy	+319,110	New	+$4.3M	0.08%	221

Other funds holding ECYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors's ECYT Position: Q1 2016 in Review

Numeric Investors sold out of Endocyte, Inc. Common Stock (ECYT) in Q1 2016, closing a stake of 122,000 shares — an estimated $489K sold.

Numeric Investors first reported a position in ECYT in Q2 2013 and held it in 10 quarters. The position peaked at $5.12M in Q4 2014. 97 funds tracked by Wall St. Rank hold ECYT as of Q1 2016.

Numeric Investors reported no remaining Endocyte, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Numeric Investors sold 122,000 Endocyte, Inc. Common Stock shares in Q1 2016, an estimated $489K.
Numeric Investors first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 10 quarters.
Numeric Investors's Endocyte, Inc. Common Stock position peaked at $5.12M in Q4 2014.
97 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2016.

Based on Numeric Investors's 13F filing for Q1 2016, filed 6 May 2016.